Oz-UK Secures European Regional Development Fund to Support Growth

Oz-UK Secures European Regional Development Funding to Support growth of its Chippenham-based laboratories, increase its headcount and provide advanced research into the replacement of harmful global warming F-Gas propellants used in Metered Dose Inhalers (MDI). OzUK specialises in the formulation and development of MDIs used for the treatment of asthma, chronic obstructive pulmonary disease, and the shift to more environmentally friendly propellant alternatives is core to continued innovation within the sector. OzUK will utilise the funding to further build out its Chippenham Respiratory R&D facility and support this transition through innovation and industry partnership.

The project is funded through the England European Regional Development Fund (ERDF) as part of the European Structural and Investment Funds Growth Programme 2014-2020 and is administered via the University of the West of England, Bristol (Fund Scheme reference 11R19P03537).

For more information visit https://www.gov.uk/european-growth-funding.